2004 - 2005: Interventional Fellowship Interventional Cardiology  Scripps Clinic La Jolla, CA

2001 - 2004: Fellowship, incl. chief fellow Cardiology  Cedars-Sinai Medical Center Los Angeles, CA

2000 - 2001: Chief Residency Internal Medicine  UCLA Medical Center Los Angeles, CA

1997 - 2000:  Internship/Residency Internal Medicine UCLA Medical Center Los Angeles, CA

1997:  Medical School Doctor of Medicine Harvard Medical School Boston, MA

1993: College Bachelor of Science, Biological Sciences Stanford University Stanford, CA

2004 - 2006: Scripps Clinic, Dr. Paul Teirstein, Dr. Richard Schatz

• investigating the efficacy and safety of treating sirolimus-eluting stent restenosis with paclitaxel-eluting stents; studying the role of plavix resistance in percutaneous coronary intervention outcomes; investigating the efficacy and safety of using eptifibatide alone as anticoagulation therapy during percutaneous interventions

2002 - 2004: Cedars-Sinai Medical Center, Dr. Raj Makkar

• investigated the effect of both G-CSF and direct stem cell infusion on the remodeling and and overall preservation/regression of LV function following balloon-occlusion acute MI in the porcine model

2004 - 2014: Cardiovascular Disease

2005 - 2015: Interventional Cardiology

2002: Cedars-Sinai Eliot Corday Fellow of the Year, Department of Cardiology

2002: Cedars-Sinai Golden Apple Fellow of the Year, Department of Internal Medicine

""The Effect of Granulocyte Colony Stimulating Factor on Regional and Global Myocardial Function in the Porcine Infarct Model." Lee SS, Naqvi TZ, Forrester J, Cattley R, Shah A, Frantzen M, Miyamoto T, Kaufman S, Price MJ, Lill M, Makkar RR. International Journal of Cardiology. In press.

"Utility of Three-Dimensional Reconstruction of Coronary Angiography to Guide Percutaneous Coronary Intervention." Gollapudi RR, Valencia R, Lee SS, Wong GB, Teirstein PS, Price MJ. Catheterization and Cardiovascular Interventions. In press.

"Ischaemic Heart Disease." Falk E, Shah PK, de Feyter PJ. 3 book chapters with Dr. PK Shah. Ischaemic Heart Disease: Primary Prevention, Collateral Development, Women and Hormones. March 2006.

"Drug-eluting Stents for Bypass Graft Lesions: Low Recurrence Rate at 6 Months." ACC Oral Presentation, 2006. Wong G, Lee SS, Gollapudi R, Valencia R, Price MJ, Schatz RA, Teirstein PS.

"Paclitaxel-eluting Stents Are More Effective in Treating Focal Patterns of Sirolimus-eluting Restenosis Compared to Non-focal Patterns of Sirolimus-eluting Stent Restenosis." ACC Abstract, 2006. Damani S, Lee SS, Sawhney N, Wong G, Gollapudi R, Valencia R, Schatz RA, Teirstein PS.

"Reduction in Major and Minor Adverse Events with Eptifibatide-based Pharmacotherapy: The REMOVE Trial." ACC Abstract, 2006. Valencia R, Sawhney N, Lee SS, Wong G, Gollapudi R, Schatz RA, Price M, Teirstein PS.

"3-Dimensional Reconstruction and Quantification of Standard Coronary Angiography Improves Drug Eluting Stent Utilization." ACC Abstract, 2006. Gollapudi R, Valencia R, Lee SS, Wong G, Teirstein PS, Price MJ.

 "Intravenous Mesenchymal Stem Cell Therapy Early After Reperfused Acute Myocardial Infarction Improves Left Ventricular Function and Alters Electrophysiologic Properties." Price MJ, Chou C, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin B, Lill M, Forrester J, Chen PS, Makkar R. International Journal of Cardiology. Oct 21, 2005.

 "Drug-eluting Stents for Bypass Graft Lesions: Low Recurrence Rate at 6 Months." TCT Abstract 2005. Wong G, Lee SS, Price MJ, Sawhney N, Schatz RA, Teirstein PS.

"Percutaneous Coronary Intervention without Anti-thrombin Therapy: The REMOVE Trial." ACC Abstract, 2005. Sawhney N, Price M, Lee SS, Wong G, Schatz RA, Teirstein PS.

"Treatment of Bifurcation Lesions with Sirolimus-Eluting Stents using the Crush and V Techniques. Procedural and Clinical Outcomes." ACC Abstract, 2005. Sawhney N, Price M, Damani S, Lee SS, Wong G, Jani A, Schatz RA, Teirstein PS.

"Stem Cell Repair of Infarcted Myocardium: Ready For Clinical Application?" Lee S, Bick- Forrester J, Makkar R, Forrester JS. The American Heart Hospital Journal. 2004, Spring Vol. 2, Issue 2.

"Coronary Brachytherapy for Bare Metal, Cypher, and Taxus Failure in a Patient with a History of CABG." TCT MD, Oct 2004. Teirstein PS, Sawhney N, Price M, Wong G, Lee SS.

"Granulocyte Colony Stimulating Factor Therapy Following Acute Myocardial Infarction Improves Global and Infarct Segment Left Ventricular Ejection Fraction." TCT Abstract, 2004. Lee S, Naqvi T, Shah A, Frantzen M, Miyamoto T, Forrester J, Lill M, Makkar R.

"Intracoronary Adipose Tissue-Derived Stem Cell Therapy Preserves Left Ventricular Function in a Porcine Infarct Model." TCT Abstract, 2004. Watanabe C, Lee S, Daniels E, Naqvi T, Shah PK, Shah A, Kar S, Fraser J, MacLellan R, Zhu M, Hedrick M, Makkar R.

"Comparison of Frequency of Left Ventricular Wall Motion Abnormalities in Patients with a First Acute Myocardial Infarction with versus without Left Ventricular Hypertrophy." Neuman Y, Cercek B, Aragon J, Lee S, Kobal S, Miyamoto T, Luo H, Tolstrup K, Naqvi TZ, Birnbaum Y, Siegel RJ. American Journal of Cardiology. Sep 15, 2004, Vol. 94, Issue 6.

"Hand-carried Cardiac Ultrasound Enhances Healthcare Delivery in Developing Countries." Kobal SL, Lee SS, Willner R, Vargas F, Luo H, Watanabe C, Neuman Y, Miyamoto T, Siegel RJ. American Journal of Cardiology. Aug 15, 2004, Vol. 94, Issue 4.

"Intravenous Mesenchymal Stem Cell Therapy Early After Reperfused Acute Myocardial Infarction Improves Left Ventricular Function and Alters Ventricular Electrophysiological Properties." ACC Abstract, 2004. Price MJ, Chou C, Frantzen M, Miyamoto T, Kar S, McClean D, Guo S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar R.

"Diabetic Dyslipidemia: A Harbinger of CHD." CME Notes. Vol. 1, Issue 5, 2002. Lee S, Wintz R, Yu M, Ansell B.

"Interleukin-1 and Transforming Growth Factor-alpha: Synergistic Stimulation of Metalloproteinases, PGE2, and Proliferation in Fibroblasts." Experimental Cell Research, Feb. 1994. Unemori EN, Ehsani N, Wang M, Lee S, Mcguire J, Amento EP.